PDM
TEVA icon

Penn Davis McFarland’s Teva Pharmaceuticals TEVA Stock Holding History

Penn Davis McFarland’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-374,068
Closed -$13.6M – 44
2016
Q4 		$13.6M Sell
374,068
-2,625
-0.7% -$105K 3.72% 9
2016
Q3 		$17.3M Sell
376,693
-2,003
-0.5% -$105K 4.44% 8
2016
Q2 		$19M Buy
378,696
+103,800
+38% +$5.53M 5.06% 6
2016
Q1 		$14.7M Sell
274,896
-7,774
-3% -$456K 3.86% 12
2015
Q4 		$18.6M Sell
282,670
-1,082
-0.4% -$66.9K 4.66% 9
2015
Q3 		$16M Sell
283,752
-12,086
-4% -$784K 4.22% 10
2015
Q2 		$17.5M Sell
295,838
-20,810
-7% -$1.28M 4.07% 9
2015
Q1 		$19.7M Sell
316,648
-7,922
-2% -$461K 4.17% 8
2014
Q4 		$19.2M Sell
324,570
-24,749
-7% -$1.38M 4.2% 8
2014
Q3 		$18M Sell
349,319
-3,660
-1% -$194K 3.92% 9
2014
Q2 		$19.2M Sell
352,979
-1,369
-0.4% -$70K 3.76% 10
2014
Q1 		$18.7M Buy
354,348
+21,903
+7% +$1.01M 3.97% 11
2013
Q4 		$13.3M Sell
332,445
-43,450
-12% -$1.71M 3.2% 13
2013
Q3 		$14.2M Buy
375,895
+5,970
+2% +$233K 3.39% 14
2013
Q2 		$14.5M Buy
+369,925
New +$14.4M 3.44% 14

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Penn Davis McFarland's TEVA Position: Q1 2017 in Review

Penn Davis McFarland sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 374,068 shares — an estimated $13.6M sold.

Penn Davis McFarland first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $19.7M in Q1 2015. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Penn Davis McFarland reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Penn Davis McFarland sold 374,068 Teva Pharmaceuticals shares in Q1 2017, an estimated $13.6M.
  • Penn Davis McFarland first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Penn Davis McFarland's Teva Pharmaceuticals position peaked at $19.7M in Q1 2015.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Penn Davis McFarland's 13F filing for Q1 2017, filed 20 Apr 2017.